Case Background:
On September 14, 2018, the initial complaint in this securities class action was filed against OPKO Health, Inc. (“OPKO” or the “Company”), and certain of OPKO’s directors and officers, asserting violations of Sections 10(b) and 20(a) of the Securities Exchange Act. This is a federal securities class action lawsuit brought on behalf of all persons or entities who purchased or acquired OPKO common stock during the period between September 26, 2013 and September 7, 2018, both dates inclusive (the “Class Period”).
The complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (1) OPKO and its Chairman and Chief Executive Officer were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny including from the SEC; and (3) as a result, Defendants’ statements about OPKO’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Current Status of Case:
On May 29, 2020, the parties informed the Court that they had reached a settlement in principle to settle this action for $16,500,000. On April 28, 2021, the Court issued an Order granting Final Approval of Settlement. This action has concluded.
The deadline to file a claim is January 26, 2021. If you have any questions or need further information about this settlement, you may go to the following website, http://www.opkohealthsecuritieslitigation.com, or you can contact the claims administrator, JND Legal Administration at 1-888-383-0345.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; or via e-mail at info@ktmc.com.